FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diphenhydramine Injection
Status: Resolved
»Duration of Shortage: 09/14/2018 - 01/25/2021
»Therapeutic Categories: Pediatric; Pulmonary/Allergy

Expand all

Fresenius Kabi USA, LLC (Revised 01/25/2021)

Company Contact Information:
888-386-1300

Presentation
  • 50 mg per vial, Single dose, Amber vial (NDC 63323-664-01)
Note:
  • N/A

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 01/25/2021)

Company Contact Information:
800-631-2174

Presentation
  • 50 mg/mL, 1 mL vial (NDC 0641-0376-25)
Note:
  • N/A

Hospira, Inc. (Revised 01/25/2021)

Company Contact Information:
844-646-4398

Presentation
  • 50 mg/mL Carpuject™ Luer Lock Glass Syringe (NDC 00409-2290-31)
Note:
  • N/A

Mylan Pharmaceuticals Inc., a Viatris Company (Revised 01/25/2021)

Company Contact Information:
800-796-9526

Presentation
  • 500 mg / 10mL(NDC 67457-124-10)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English